MADRIGAL PHARMACEUTICALS INC USD0.0001 financial statements, including revenue, expenses, and profit
The total revenue of 0JXI for the last quarter is 103.32 M USD, and it's 66.18% higher compared to the previous quarter. The net income of Q4 24 is -59.42 M USD.